𧬠Gene Therapy Breakthrough Gets FDA Nod
Ultragenyx has secured the first FDA approval for a gene therapy targeting a rare metabolic disorder. This milestone was achieved for the company, Ultragenyx, in the United States. The approval came after extensive clinical trials, marking a significant moment for rare disease treatment. The therapy offers hope to patients suffering from this previously hard-to-treat condition. Further phases of research are planned to expand its application globally. π§¬